Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40292-020-00396-9 http://scihub22266oqcxt.onion/10.1007/s40292-020-00396-9 32578165!7309212!32578165     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       High+Blood+Press+Cardiovasc+Prev 2020 ; 27 (5): 349-362 Nephropedia Template TP {{tp|p=32578165|t=2020. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice |pdf=|usr=}}{{32578165}} gab.com Text Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice JO: High Blood Press Cardiovasc Prev http://www.kidney.de/pget.php?&tw=1&pmid=32578165 #FOAvip Tobacco use is one of the major public health concerns and it is the most preventable cause of morbidity and mortality worldwide. Smoking cessation reduces subsequent cardiovascular events and mortality. Smoking is a real chronic disorder characterized by the development of an addiction status mainly due to nicotine. This condition makes the smokers generally unable to quit smoking without help. Different strategies are available to treat smoking dependence that include both non-pharmacological (behavioral counselling) and pharmacological therapies. Currently, it is well accepted that smoking cessation drugs are effective and safe in real-world settings. Nicotine replacement therapy (NRT), varenicline, bupropion and cytisine are the main pharmacological strategies available for smoking cessation. Their efficacy and safety have been proved even in patients with chronic cardiovascular disease. Each of these drugs has peculiar characteristics and the clinician should customize the smoking cessation strategy based on currently available scientific evidence and patient's preference, paying particular attention to those patients having specific cardiovascular and psychiatric comorbidities. The present document aims to summarize the current viable pharmacological strategies for smoking cessation, also discussing the controversial issue regarding the use of alternative tobacco products, in order to provide useful practical indications to all physicians, mainly to those involved in cardiovascular prevention. Twit Text FOAVip Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice ????High Blood Press Cardiovasc Prev http://www.kidney.de/pget.php?&tw=1&pmid=32578165 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32578165 #FOAvip English Wikipedia <ref>{{Cite pmid|32578165}}</ref> Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice #MMPMID32578165 Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R High Blood Press Cardiovasc Prev 2020[Oct]; 27 (5): 349-362 PMID32578165show ga Tobacco use is one of the major public health concerns and it is the most preventable cause of morbidity and mortality worldwide. Smoking cessation reduces subsequent cardiovascular events and mortality. Smoking is a real chronic disorder characterized by the development of an addiction status mainly due to nicotine. This condition makes the smokers generally unable to quit smoking without help. Different strategies are available to treat smoking dependence that include both non-pharmacological (behavioral counselling) and pharmacological therapies. Currently, it is well accepted that smoking cessation drugs are effective and safe in real-world settings. Nicotine replacement therapy (NRT), varenicline, bupropion and cytisine are the main pharmacological strategies available for smoking cessation. Their efficacy and safety have been proved even in patients with chronic cardiovascular disease. Each of these drugs has peculiar characteristics and the clinician should customize the smoking cessation strategy based on currently available scientific evidence and patient's preference, paying particular attention to those patients having specific cardiovascular and psychiatric comorbidities. The present document aims to summarize the current viable pharmacological strategies for smoking cessation, also discussing the controversial issue regarding the use of alternative tobacco products, in order to provide useful practical indications to all physicians, mainly to those involved in cardiovascular prevention. |*Smoking Cessation[MESH] |Alkaloids/adverse effects/*therapeutic use[MESH] |Azocines/adverse effects/therapeutic use[MESH] |Bupropion/adverse effects/*therapeutic use[MESH] |Clinical Decision-Making[MESH] |Electronic Nicotine Delivery Systems[MESH] |Humans[MESH] |Quinolizines/adverse effects/therapeutic use[MESH] |Recurrence[MESH] |Risk Factors[MESH] |Smoking Cessation Agents/adverse effects/*therapeutic use[MESH] |Smoking/*adverse effects[MESH] |Tobacco Use Cessation Devices[MESH] |Tobacco Use Disorder/diagnosis/*drug therapy/physiopathology/psychology[MESH] |Treatment Outcome[MESH]Pharmacological Approach to Smoking Cessation: An Updated Review for D(epmc).pdf DeepDyve Pubget Overpricing